Adam Crowe

Adam Crowe manages a multi-discipline team at Cytiva tasked with developing novel analytical assays related to lipid nanoparticles (LNP) and nanomaterials for drug delivery. Notably, Adam and his team have increasingly leveraged cutting-edge technologies, such as LC-MS approaches, to tackle the complexities of LNP characterization. Latest studies were focused on the detailed characterization of impurities found in ionizable lipids.